Review article: the therapeutic potential of 5‐HT3receptor antagonists in the treatment of irritable bowel syndrome
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
There is evidence from studies, in both animals and humans, that 5‐HT 3 receptor blockade has potential value in the treatment of irritable bowel syndrome, particularly in those patients with diarrhoea‐predominant bowel habits. New findings suggest that 5‐HT 3 receptors exist on gut afferent neurones and that their activation by locally released 5‐HT leads to visceral nociceptive stimulation, in addition to increased neuronally‐mediated motor and secretory activity. If this concept is validated, it will provide a rationale for the use of 5‐HT 3 receptor antagonists in patients with increased gut motility, reduced fluid absorption and low nociceptive thresholds leading to abdominal pain. Alosetron is a highly selective, potent 5‐HT 3 receptor antagonist which is well absorbed with a long pharmacodynamic half‐life. Its ability to provide long‐lasting blockade of 5‐HT 3 receptors throughout the body make it an ideal candidate within its class to evaluate the clinical hypothesis that sustained and ubiquitous 5‐HT 3 receptor blockade is of value in the treatment of IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
Delvaux, M., Louvel, D., Mamet, J. ‐., Campos‐Oriola, R., & Frexinos, J. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00375.x · Cited by 236
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Nerves, Reflexes, and the Enteric Nervous System: Pathogenesis of the Irritable Bowel Syndrome
Gershon, M. D. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156403.37240.30 · Cited by 271
Niesler, B., Frank, B., Kapeller, J., & Rappold, G. A. (2003) · Gene · doi:10.1016/s0378-1119(03)00503-1 · Cited by 252
Houghton, Foster, & Whorwell (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00762.x · Cited by 132
Metadata
- Authors
- Humphrey, P. P. A., Bountra, C., Clayton, N., & Kozlowski, K.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1999-05
- Volume
- 13
- Issue
- s2
- Pages
- 31-38
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2083665563
- Cited by
- 94
- References
- 1
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: the therapeutic potential of 5‐HT3receptor antagonists in the treatment of irritable bowel syndrome. https://app.cochat.ai/papers/10.1046/j.1365-2036.1999.00003.x-i2
- The paper
- Humphrey, P. P. A., Bountra, C., Clayton, N., & Kozlowski, K. (1999). Review article: the therapeutic potential of 5‐HT3receptor antagonists in the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.